Bentic, Fausto S.
HRN: 08-37-72 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/18/2025
RIFAXIMIN 200MG (TAB)
04/18/2025
04/25/2025
PO
400mg
2 Tabs BID
Hepatic Enceph
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes